views
The report "Pharmaceutical Processing Seals Market by Material (Metals, PTFE, Nitrile Rubber, Silicone, EPDM, FKM, FFKM, UHMWPE, PU), Type (O-Ring Seals, Gaskets, Lip Seals, D Seals), Application (Manufacturing Equipment), and Region - Global Forecast to 2026", The pharmaceutical processing seals market is projected to grow from USD 2.1 billion in 2021 to USD 3.3 billion by 2026, at a CAGR of 10.0% during the forecast period. The growth of pharmaceutical processing seals market is attributed to the increased demand for pharmaceutical manufacturing equipment due to the growing healthcare industry and increasing consumption of pharmaceutical drugs. In addition, the expansion of healthcare industry in APAC due to favorable trade policies proposed by the government of countries in this region is expected to drive the pharmaceutical processing seals market.
APAC is projected to be the fastest-growing pharmaceutical processing seals market. The growth of the APAC pharmaceutical processing seals market can be attributed to the growing investment in capacity expansion of the healthcare industry, along with the increasing pharmaceutical equipment production due to the favorable rules and regulations in the region. Additionally, the growth in the demand for new and improved pharmaceutical drugs catering to critical medical conditions has boosted the need for domestic pharmaceutical manufacturing, which is expected to drive the market for pharmaceutical manufacturing equipment and thus, increase the demand for pharmaceutical processing seals in the region.
Most active players in the pharmaceutical processing seals market:
Trelleborg AB (Sweden), Freudenberg Group (Germany), Flowserve Corporation (US), James Walker (UK), Parker Hannifin Corporation (US), Saint-Gobain S.A. (France), Garlock (US), John Crane (US), IDEX Corporation (US), and Morgan Advanced Materials PLC (UK) are the leading players operating in the pharmaceutical processing seals market.